Plausible Deniability - The rise of the doctrine of plausibility in the European patent prosecution and litigation

Plausible Deniability - The rise of the doctrine of plausibility in the European patent prosecution and litigation

Speakers: Ravi Srinivasan and Andrew Clark, partners at J A Kemp

Recent cases show that both the UK courts and the EPO Boards of Appeal are taking an increasingly strict approach in requiring a plausible disclosure of efficacy in the specification as filed when assessing claims involving pharmaceutical products (both small and large molecules). All those working in the pharmaceutical field ought to have a clear and up to date understanding of legal developments in this area. We will walk through the key UK and EPO cases in this area, and also spend some time discussion how these legal developments should affect our drafting practice. 

If you are overseas and would like to book onto this webinar, please email cpd@cipa.org.uk to ensure that you receive a Non-VAT invoice.

Event information

Plausible Deniability - The rise of the doctrine of plausibility in the European patent prosecution and litigation
Start date Monday, July 10, 2017 12:30 PM
End date Monday, July 10, 2017 01:30 PM
CPD Points 1.0
Price Non Member £72.00 (Includes £12.00 VAT)
Member £48.00 (Includes £8.00 VAT)